Administrative Supplements for P30 Cancer Centers Support Grants (CCSG) to Enhance the Utility of Data Available through the Childhood Cancer Data Initiative (CCDI) Ecosystem

Organization
NCI
Type
Internal
Application Due Date
06-30-2023
Comments
If interested in applying, contact Sarah Laye at slaye@som.umaryland.edu
Brief Description

The NCI’s Center for Biomedical Informatics and Information Technology (CBIIT) announces the opportunity for funding NCI-designated Cancer Centers, in collaboration with appropriate pediatric cancer-focused affiliates (e.g., research centers, pediatric care hospitals, foundations, commercial partners, etc.), through P30 CCSG supplements to enhance the usability and utility of data in the CCDI data ecosystem and other relevant pediatric cancer data. The purpose of the administrative supplement is to provide the Cancer Centers with additional resources to aggregate, integrate, analyze and visualize pediatric cancer data from a variety of sources as a demonstration to enhance secondary reuse of data in this population. Ultimately, NCI seeks to use resources in the CCDI data ecosystem to accelerate the understanding of childhood cancer biology and identify potential for therapeutic translation through a more unified lens (e.g., identification of biomarkers predictive of therapeutic outcome in rare tumors).

Eligibility and Budget 

- This opportunity is open to all currently funded NCI-Designated Cancer Centers.

- The Center Director must be the PI of the supplement; you may name project leader(s) and point-of-contacts (POCs) with DMS oversight responsibilities in the application separately.

- No limit on the number of administrative supplement applications per Cancer Center.

- Supplement requests may not exceed $500,000 in total costs, and the project period is for one year. No-cost extension for the supplement awards will be limited to an additional 12 months if needed.

- Cancer Centers whose P30 CCSGs will be on an extension at the time the award is made in FY23 are not eligible for this supplement.  It is anticipated that awards for this supplement opportunity will be made in September 2023 at the earliest.